1
|
Policar M, Madad S. Overcoming COVID-19 Misinformation: Lessons Learned at the Epicentre of the Outbreak in the USA. EMJ Microbiol Infect Dis 2022. [DOI: 10.33590/emjmicrobiolinfectdis/10072885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
THE COVID-19 pandemic has highlighted the dire need to foster increased public confidence in mitigation and prevention strategies through more and better health literacy. More than 2 years into the worst public health crisis of the 21st century, we continue to be consumed by the most basic health questions: should I get tested for COVID-19, should I get vaccinated and boosted against COVID-19, and should I wear a mask? In many countries, the tension between personal freedoms and public good helps to fuel a global threat, with continued transmission of severe acute respiratory syndrome coronavirus 2 and its evolving, more infectious variants. This short essay discusses the negative effects of misinformation and disinformation, and shares recommendations based on lessons learned.
Collapse
Affiliation(s)
- Maurice Policar
- NYC Health + Hospitals/Elmhurst, New York City, New York, USA; Icahn School of Medicine at Mount Sinai, New York City, New York, USA
| | - Syra Madad
- System-wide Special Pathogens Program, NYC Health + Hospitals, New York City, New York, USA; Belfer Center for Science and International Affairs, Harvard University, Cambridge, Massachusetts, USA
| |
Collapse
|
2
|
Udeagu CCN, Huang J, Misra K, Terilli T, Ramos Y, Alexander M, Kim C, Madad S, Williams R, Bethala S, Pitiranggon M, Blaney K, Keeley C, Bray J, Long T, Vora NM. Community-Based Workforce for COVID-19 Contact Tracing and Prevention Activities in New York City, July-December 2020. Public Health Rep 2022; 137:46S-50S. [PMID: 35861302 PMCID: PMC9679199 DOI: 10.1177/00333549221110833] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
OBJECTIVES High rates of hospitalization and death disproportionately affected Black, Latino, and Asian residents of New York City at the beginning of the COVID-19 pandemic. To suppress COVID-19 transmission, New York City implemented a workforce of community engagement specialists (CESs) to conduct home-based contact tracing when telephone numbers were lacking or telephone-based efforts were unsuccessful and to disseminate COVID-19 information and sanitary supplies. MATERIALS AND METHODS We describe the recruitment, training, and deployment of a multilingual CES workforce with diverse sociodemographic backgrounds during July-December 2020 in New York City. We developed standard operating procedures for infection control and safety measures, procured supplies and means of transportation, and developed protocols and algorithms to efficiently distribute workload. RESULTS From July through December 2020, 519 CESs were trained to conduct in-person contact tracing and activities in community settings, including homes, schools, and businesses, where they disseminated educational materials, face masks, hand sanitizer, and home-based specimen collection kits. During the study period, 94 704 records of people with COVID-19 and 61 246 contacts not reached by telephone-based contact tracers were referred to CESs. CESs attempted home visits or telephone calls with 84 230 people with COVID-19 and 49 303 contacts, reaching approximately 55 592 (66%) and 35 005 (71%), respectively. Other CES activities included monitoring recently arrived travelers under quarantine, eliciting contacts at point-of-care testing sites, and advising schools on school-based COVID-19 mitigation strategies. PRACTICE IMPLICATIONS This diverse CES workforce allowed for safe, in-person implementation of contact tracing and other prevention services for individuals and communities impacted by COVID-19. This approach prioritized equitable delivery of community-based support services and resources.
Collapse
Affiliation(s)
- Chi-Chi N. Udeagu
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Jamie Huang
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Kavita Misra
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Thomas Terilli
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Yasmin Ramos
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Martha Alexander
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Christine Kim
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Syra Madad
- New York City Test & Trace Corps, New York, NY, USA
- New York City Health + Hospitals Corporation, New York, NY, USA
| | - Reba Williams
- New York City Test & Trace Corps, New York, NY, USA
- New York City Health + Hospitals Corporation, New York, NY, USA
| | - Samira Bethala
- New York City Test & Trace Corps, New York, NY, USA
- New York City Health + Hospitals Corporation, New York, NY, USA
| | - Masha Pitiranggon
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Kathleen Blaney
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| | - Chris Keeley
- New York City Test & Trace Corps, New York, NY, USA
- New York City Health + Hospitals Corporation, New York, NY, USA
| | - Jackie Bray
- New York City Test & Trace Corps, New York, NY, USA
- Office of the Mayor, City of New York, New York, NY, USA
| | - Theodore Long
- New York City Test & Trace Corps, New York, NY, USA
- New York City Health + Hospitals Corporation, New York, NY, USA
| | - Neil M. Vora
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
- New York City Test & Trace Corps, New York, NY, USA
| |
Collapse
|
3
|
Shah YB, Glatter R, Madad S. In Layman's Terms: The Power and Problem of Science Communication. Disaster Med Public Health Prep 2022; 16:1-3. [PMID: 35757894 DOI: 10.1017/dmp.2022.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Improved policies for science communication are needed to ensure scientific progress in coming decades. The COVID-19 pandemic illustrated massive gaps in science communication, ranging from masking and social distancing mandates to vaccination requirements. These obstacles compounded the pandemic's tremendous inherent clinical and public health challenges. Although science made immense progress in understanding the virus and designing infection control solutions, society still remains within the pandemic due to flawed understanding, low responsiveness, and widespread misinformation on behalf of the public. Flawed communication plagues national responses not only to the pandemic, but also other long-standing issues such as climate change or nutrition. This Letter proposes a new protocol and framework for effective science communication, designed to educate experts in evidence-based communication, improve public partnership through relatability and modern relevance, and increase empathy and trustworthiness to increase public cooperation. A defined protocol for science communication can ensure that evolving knowledge can tangibly benefit society.
Collapse
Affiliation(s)
- Yash B Shah
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA
| | - Robert Glatter
- Department of Emergency Medicine, Lenox Hill Hospital, Northwell Health, New York, NY
| | - Syra Madad
- Special Pathogens Program Office, NYC Health + Hospitals, New York, NY
- Belfer Center for Science and International Affairs, Harvard University, Cambridge, MA
| |
Collapse
|
4
|
Madad S, Davis NJ, Adams A, Rosenstock P, Dhagat P, Kalyanaraman Marcello R. Building Confidence in COVID-19 Vaccines Through Effective Communication. Health Secur 2021; 20:92-95. [PMID: 34919473 DOI: 10.1089/hs.2021.0180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Syra Madad
- Syra Madad, DHSc, MSc, is Senior Director, System-Wide Special Pathogens Program, and Lead, COVID-19 Vaccine Communications and Outreach Workgroup, Central Office Emergency Management; Nichola J. Davis, MD, MS, is Vice President and Chief Population Health Officer, Office of Ambulatory Care and Population Health; Philip Rosenstock, MD, is a System Clinical Integration Officer, Office of Medical and Professional Affairs; Priya Dhagat, MS, MLS, CIC, is Associate Director, System-Wide Special Pathogens Program, Central Office Emergency Management; and Roopa Kalyanaraman Marcello, MPH, is Senior Director, Research and Evaluation, Office of Ambulatory Care and Population Health; all at New York City Health + Hospitals, New York, NY. Nichola J. Davis is also a Clinical Professor, Department of Population Health, and Ayrenne Adams, MD, MPH, is a Clinical Assistant Professor, Department of Medicine; both at NYU Grossman School of Medicine, New York, NY
| | - Nichola J Davis
- Syra Madad, DHSc, MSc, is Senior Director, System-Wide Special Pathogens Program, and Lead, COVID-19 Vaccine Communications and Outreach Workgroup, Central Office Emergency Management; Nichola J. Davis, MD, MS, is Vice President and Chief Population Health Officer, Office of Ambulatory Care and Population Health; Philip Rosenstock, MD, is a System Clinical Integration Officer, Office of Medical and Professional Affairs; Priya Dhagat, MS, MLS, CIC, is Associate Director, System-Wide Special Pathogens Program, Central Office Emergency Management; and Roopa Kalyanaraman Marcello, MPH, is Senior Director, Research and Evaluation, Office of Ambulatory Care and Population Health; all at New York City Health + Hospitals, New York, NY. Nichola J. Davis is also a Clinical Professor, Department of Population Health, and Ayrenne Adams, MD, MPH, is a Clinical Assistant Professor, Department of Medicine; both at NYU Grossman School of Medicine, New York, NY
| | - Ayrenne Adams
- Syra Madad, DHSc, MSc, is Senior Director, System-Wide Special Pathogens Program, and Lead, COVID-19 Vaccine Communications and Outreach Workgroup, Central Office Emergency Management; Nichola J. Davis, MD, MS, is Vice President and Chief Population Health Officer, Office of Ambulatory Care and Population Health; Philip Rosenstock, MD, is a System Clinical Integration Officer, Office of Medical and Professional Affairs; Priya Dhagat, MS, MLS, CIC, is Associate Director, System-Wide Special Pathogens Program, Central Office Emergency Management; and Roopa Kalyanaraman Marcello, MPH, is Senior Director, Research and Evaluation, Office of Ambulatory Care and Population Health; all at New York City Health + Hospitals, New York, NY. Nichola J. Davis is also a Clinical Professor, Department of Population Health, and Ayrenne Adams, MD, MPH, is a Clinical Assistant Professor, Department of Medicine; both at NYU Grossman School of Medicine, New York, NY
| | - Philip Rosenstock
- Syra Madad, DHSc, MSc, is Senior Director, System-Wide Special Pathogens Program, and Lead, COVID-19 Vaccine Communications and Outreach Workgroup, Central Office Emergency Management; Nichola J. Davis, MD, MS, is Vice President and Chief Population Health Officer, Office of Ambulatory Care and Population Health; Philip Rosenstock, MD, is a System Clinical Integration Officer, Office of Medical and Professional Affairs; Priya Dhagat, MS, MLS, CIC, is Associate Director, System-Wide Special Pathogens Program, Central Office Emergency Management; and Roopa Kalyanaraman Marcello, MPH, is Senior Director, Research and Evaluation, Office of Ambulatory Care and Population Health; all at New York City Health + Hospitals, New York, NY. Nichola J. Davis is also a Clinical Professor, Department of Population Health, and Ayrenne Adams, MD, MPH, is a Clinical Assistant Professor, Department of Medicine; both at NYU Grossman School of Medicine, New York, NY
| | - Priya Dhagat
- Syra Madad, DHSc, MSc, is Senior Director, System-Wide Special Pathogens Program, and Lead, COVID-19 Vaccine Communications and Outreach Workgroup, Central Office Emergency Management; Nichola J. Davis, MD, MS, is Vice President and Chief Population Health Officer, Office of Ambulatory Care and Population Health; Philip Rosenstock, MD, is a System Clinical Integration Officer, Office of Medical and Professional Affairs; Priya Dhagat, MS, MLS, CIC, is Associate Director, System-Wide Special Pathogens Program, Central Office Emergency Management; and Roopa Kalyanaraman Marcello, MPH, is Senior Director, Research and Evaluation, Office of Ambulatory Care and Population Health; all at New York City Health + Hospitals, New York, NY. Nichola J. Davis is also a Clinical Professor, Department of Population Health, and Ayrenne Adams, MD, MPH, is a Clinical Assistant Professor, Department of Medicine; both at NYU Grossman School of Medicine, New York, NY
| | - Roopa Kalyanaraman Marcello
- Syra Madad, DHSc, MSc, is Senior Director, System-Wide Special Pathogens Program, and Lead, COVID-19 Vaccine Communications and Outreach Workgroup, Central Office Emergency Management; Nichola J. Davis, MD, MS, is Vice President and Chief Population Health Officer, Office of Ambulatory Care and Population Health; Philip Rosenstock, MD, is a System Clinical Integration Officer, Office of Medical and Professional Affairs; Priya Dhagat, MS, MLS, CIC, is Associate Director, System-Wide Special Pathogens Program, Central Office Emergency Management; and Roopa Kalyanaraman Marcello, MPH, is Senior Director, Research and Evaluation, Office of Ambulatory Care and Population Health; all at New York City Health + Hospitals, New York, NY. Nichola J. Davis is also a Clinical Professor, Department of Population Health, and Ayrenne Adams, MD, MPH, is a Clinical Assistant Professor, Department of Medicine; both at NYU Grossman School of Medicine, New York, NY
| |
Collapse
|
5
|
Al-Salem W, Moraga P, Ghazi H, Madad S, Hotez PJ. The emergence and transmission of COVID-19 in European countries, 2019-2020: a comprehensive review of timelines, cases and containment. Int Health 2021; 13:383-398. [PMID: 34333650 PMCID: PMC8385807 DOI: 10.1093/inthealth/ihab037] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 03/14/2021] [Accepted: 07/28/2021] [Indexed: 11/16/2022] Open
Abstract
When it emerged in late 2019, COVID-19 was carried via travelers to Germany, France and Italy, where freedom of movement accelerated its transmission throughout Europe. However, effective non-pharmaceutical interventions introduced by European governments led to containment of the rapid increase in cases within European nations. Electronic searches were performed to obtain the number of confirmed cases, incident rates and non-pharmaceutical government measures for each European country. The spread and impact of non-pharmaceutical interventions throughout Europe were assessed and visualized. Specifically, heatmaps were used to represent the number of confirmed cases and incident rates for each of the countries over time. In addition, maps were created showing the number of confirmed cases and incident rates in Europe on three different dates (15 March, 15 April and 15 May 2020), which allowed us to assess the geographic and temporal patterns of the disease.
Collapse
Affiliation(s)
- Waleed Al-Salem
- Department of Public Health, Ministry of Health, Riyadh, Saudi Arabia
| | - Paula Moraga
- Computer, Electrical and Mathematical Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia
| | - Hani Ghazi
- School of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
| | - Syra Madad
- Special Pathogens Program, NYC Health, New York, USA
- Harvard Kennedy School, Belfer Center for Science and International Affairs, New York, USA
| | - Peter J Hotez
- Texas Children's Hospital Center for Vaccine Development, Texas Children's Hospital, Houston, Texas, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
- Department of Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA
| |
Collapse
|
6
|
Affiliation(s)
- Syra Madad
- System Special Pathogens Program, NYC Health + Hospitals, New York, NY 10016, USA.
| | - Craig Spencer
- Department of Medicine, Columbia University, New York, NY, USA
| |
Collapse
|
7
|
Madad S. Preparing Frontline Hospitals for Dangerous Special Pathogens Beyond Ebola. Health Secur 2020; 19:209-213. [PMID: 33351700 DOI: 10.1089/hs.2020.0134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Frontline hospitals are at the forefront of all travel-related, emerging and reemerging infectious diseases and special pathogens. Yet, the readiness of frontline hospitals and their ability to identify, isolate, and inform on Ebola and other special pathogens is uncertain. This article addresses the resources necessary to support screening for Ebola and other special pathogens and presents the decision-making algorithm for the transport of patients with high-consequence infectious diseases within the New York City Health + Hospitals integrated healthcare delivery network, which includes 10 frontline hospitals and the Region 2 Ebola and Other Special Pathogen Treatment Center.
Collapse
Affiliation(s)
- Syra Madad
- Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and is Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps; both with New York City Health + Hospitals, New York, NY
| |
Collapse
|
8
|
Cable J, Heymann DL, Uzicanin A, Tomori O, Marinissen MJ, Katz R, Kerr L, Lurie N, Parker GW, Madad S, Maldin Morgenthau B, Osterholm MT, Borio L. Pandemic diseases preparedness and response in the age of COVID-19-a symposium report. Ann N Y Acad Sci 2020; 1489:17-29. [PMID: 33155324 DOI: 10.1111/nyas.14534] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2020] [Accepted: 10/27/2020] [Indexed: 10/23/2022]
Abstract
For years, experts have warned that a global pandemic was only a matter of time. Indeed, over the past two decades, several outbreaks and pandemics, from SARS to Ebola, have tested our ability to respond to a disease threat and provided the opportunity to refine our preparedness systems. However, when a novel coronavirus with human-to-human transmissibility emerged in China in 2019, many of these systems were found lacking. From international disputes over data and resources to individual disagreements over the effectiveness of facemasks, the COVID-19 pandemic has revealed several vulnerabilities. As of early November 2020, the WHO has confirmed over 46 million cases and 1.2 million deaths worldwide. While the world will likely be reeling from the effects of COVID-19 for months, and perhaps years, to come, one key question must be asked, How can we do better next time? This report summarizes views of experts from around the world on how lessons from past pandemics have shaped our current disease preparedness and response efforts, and how the COVID-19 pandemic may offer an opportunity to reinvent public health and healthcare systems to be more robust the next time a major challenge appears.
Collapse
Affiliation(s)
| | - David L Heymann
- Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom
| | - Amra Uzicanin
- Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | | | - Maria Julia Marinissen
- Division of International Health Security, Office of Policy and Planning, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health & Human Services, Washington, DC
| | - Rebecca Katz
- Center for Global Health Science and Security, Georgetown University, Washington, DC
| | - Larry Kerr
- U.S. Department of Health & Human Services, Office of Global Affairs, Washington, DC
| | - Nicole Lurie
- Coalition for Epidemic Preparedness Innovations, Oslo, Norway
| | - Gerald W Parker
- College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas
| | - Syra Madad
- System-wide Special Pathogens Program, Central Office Emergency Management, Institute for Diseases and Disaster Management, New York, New York.,NYC Health+Hospitals, New York, New York
| | | | | | | |
Collapse
|
9
|
Jordan-Martin NC, Madad S, Alves L, Wang J, O'Gere L, Smith YG, Pressman M, Shure JA, Cosmi M. Isolation Hotels: A Community-Based Intervention to Mitigate the Spread of the COVID-19 Pandemic. Health Secur 2020; 18:377-382. [PMID: 32986473 DOI: 10.1089/hs.2020.0123] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Nicole C Jordan-Martin
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| | - Syra Madad
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| | - Laura Alves
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| | - Janet Wang
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| | - Latoya O'Gere
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| | - Yolanda G Smith
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| | - Marcy Pressman
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| | - Jared A Shure
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| | - Michael Cosmi
- Nicole C. Jordan-Martin, MPA, is Executive Director and Chief Executive Officer; Laura Alves, MHA, PMP, CPHQ, is Associate Executive Director, Care Management; Janet Wang, is Director, Care Management; Latoya O'Gere, MSN, is Associate Executive Director, Chronic Disease and Performance Improvement; Yolanda G. Smith, RN, MSN, is Deputy Executive Director and Chief Nursing Officer; Marcy Pressman, MPH, is Deputy Executive Director, Care Management; Jared A. Shure, is Deputy Executive Director and Chief Financial Officer; Michael Cosmi, is Director, Information Technology; all at New York City Health + Hospitals (NYC H+H)/Community Care, New York, NY. Syra Madad, DHSc, MSc, MCP, is Senior Director, System-Wide Special Pathogens Program, Emergency Management, and Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, at NYC H+H, New York, NY
| |
Collapse
|
10
|
Shearer MP, Meyer D, Hosangadi D, Snyder MR, Trotochaud M, Madad S, Nuzzo JB. Operational stresses on New York City Health+Hospitals Health System frontline hospitals during the 2017-18 influenza season. Am J Disaster Med 2020; 15:99-111. [PMID: 32804390 DOI: 10.5055/ajdm.2020.0360] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVE Identify operational lessons to support hospital and health system preparedness and response for sea-sonal and pandemic influenza based on firsthand experiences from the 2017-2018 influenza season. DESIGN We conducted semistructured, retrospective interviews with New York City Health+Hospitals (NYCH+H) personnel to gather firsthand experiences from the 2017-2018 influenza season and evaluated stress data across four operational domains reported by NYCH+H hospitals during the 2017-2018 influenza season. SETTING Frontline hospitals in the NYCH+H health system during and after the 2017-2018 influenza season. PARTICIPANTS Interviews conducted with personnel from 5 NYCH+H frontline hospitals. Operational stress data re-ported by 11 NYCH+H hospitals during the 2017-2018 influenza season. MAIN OUTCOME MEASURES Operational challenges and lessons from frontline hospitals responding to severe sea-sonal influenza. RESULTS Operational stresses during the 2017-2018 influenza season varied over the influenza season, between facilities, and across operational domains. Patient surge and staff absenteeism pushed some facilities to their limits, and supply shortages highlighted shortcomings in existing procurement systems. Resources tied to pandemic influ-enza were unavailable without a pandemic declaration. CONCLUSION Seasonal influenza poses dynamic operational stresses across health systems and cities, potentially causing major impacts outside of declared pandemics. Lessons from NYCH+H can help other hospitals and health systems anticipate operational challenges, but novel solutions are needed to mitigate effects of patient surge and per-sonnel and supply shortages during severe influenza seasons and pandemics. Improved data collection can help health systems better understand operational stresses and challenges across their facilities.
Collapse
Affiliation(s)
- Matthew P Shearer
- Senior Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Diane Meyer
- Senior Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Depart-ment of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Divya Hosangadi
- Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Depart-ment of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Michael R Snyder
- Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Depart-ment of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Marc Trotochaud
- Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Depart-ment of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Syra Madad
- Senior Director, System-wide Special Pathogens Program, Central Office Emergency Manage-ment, Center for Global Healthcare Special Pathogens Preparedness, New York City, New York; Health+Hospitals, New York City, New York
| | - Jennifer B Nuzzo
- Senior Scholar, Johns Hopkins Center for Health Security, Baltimore, Maryland; Associate Profes-sor, Department of Environmental Health and Engineering and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| |
Collapse
|
11
|
Cagliuso NV, McGinty M, Madad S. Fierce Advocates for Building All-Hazards Resurgence and Resilience: NYC Health + Hospitals' COVID-19 Experiences Applied. Health Secur 2020; 18:360-362. [PMID: 32706596 DOI: 10.1089/hs.2020.0100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Nicholas V Cagliuso
- Nicholas V. Cagliuso, Sr., PhD, MPH, is Senior Assistant Vice President; Meghan McGinty, PhD, MPH, MBA, is Director, Emergency Management Planning, Resilience, and Recovery; Syra Madad, DHSc, MSc, MCP, is Senior Director of the System-Wide Special Pathogens Program; all in Emergency Management, New York City Health + Hospitals, New York, NY. Syra Madad is also Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, New York City Health + Hospitals, New York, NY
| | - Meghan McGinty
- Nicholas V. Cagliuso, Sr., PhD, MPH, is Senior Assistant Vice President; Meghan McGinty, PhD, MPH, MBA, is Director, Emergency Management Planning, Resilience, and Recovery; Syra Madad, DHSc, MSc, MCP, is Senior Director of the System-Wide Special Pathogens Program; all in Emergency Management, New York City Health + Hospitals, New York, NY. Syra Madad is also Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, New York City Health + Hospitals, New York, NY
| | - Syra Madad
- Nicholas V. Cagliuso, Sr., PhD, MPH, is Senior Assistant Vice President; Meghan McGinty, PhD, MPH, MBA, is Director, Emergency Management Planning, Resilience, and Recovery; Syra Madad, DHSc, MSc, MCP, is Senior Director of the System-Wide Special Pathogens Program; all in Emergency Management, New York City Health + Hospitals, New York, NY. Syra Madad is also Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps, New York City Health + Hospitals, New York, NY
| |
Collapse
|
12
|
Affiliation(s)
- Syra Madad
- Syra Madad, DHSc, MSc, MCP, is Senior Director and Priya Dhagat, MS, MLS(ASCP), CIC, is Assistant Director, System-Wide Special Pathogens Program, Emergency Management; Syra Madad is also Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps; both with New York City Health + Hospitals, New York, NY
| | - Priya Dhagat
- Syra Madad, DHSc, MSc, MCP, is Senior Director and Priya Dhagat, MS, MLS(ASCP), CIC, is Assistant Director, System-Wide Special Pathogens Program, Emergency Management; Syra Madad is also Health and Safety Lead, Enhanced Special Investigations Unit, NYC Test & Trace Corps; both with New York City Health + Hospitals, New York, NY
| |
Collapse
|
13
|
Shearer MP, Meyer D, Hosangadi D, Snyder MR, Trotochaud M, Madad S, Nuzzo JB. Operational stresses on New York City Health+Hospitals Health System frontline hospitals during the 2017-18 influenza season. J Emerg Manag 2020; 18:191-203. [PMID: 32441036 DOI: 10.5055/jem.2020.0465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVE Identify operational lessons to support hospital and health system preparedness and response for sea-sonal and pandemic influenza based on firsthand experiences from the 2017-2018 influenza season. DESIGN We conducted semistructured, retrospective interviews with New York City Health+Hospitals (NYCH+H) personnel to gather firsthand experiences from the 2017-2018 influenza season and evaluated stress data across four operational domains reported by NYCH+H hospitals during the 2017-2018 influenza season. SETTING Frontline hospitals in the NYCH+H health system during and after the 2017-2018 influenza season. PARTICIPANTS Interviews conducted with personnel from 5 NYCH+H frontline hospitals. Operational stress data reported by 11 NYCH+H hospitals during the 2017-2018 influenza season. MAIN OUTCOME MEASURES Operational challenges and lessons from frontline hospitals responding to severe seasonal influenza. RESULTS Operational stresses during the 2017-2018 influenza season varied over the influenza season, between facilities, and across operational domains. Patient surge and staff absenteeism pushed some facilities to their limits, and supply shortages highlighted shortcomings in existing procurement systems. Resources tied to pandemic influ-enza were unavailable without a pandemic declaration. CONCLUSION Seasonal influenza poses dynamic operational stresses across health systems and cities, poten-tially causing major impacts outside of declared pandemics. Lessons from NYCH+H can help other hospitals and health systems anticipate operational challenges, but novel solutions are needed to mitigate effects of patient surge and personnel and supply shortages during severe influenza seasons and pandemics. Improved data collection can help health systems better understand operational stresses and challenges across their facilities.
Collapse
Affiliation(s)
- Matthew P Shearer
- Senior Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Diane Meyer
- Senior Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Divya Hosangadi
- Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Michael R Snyder
- Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Marc Trotochaud
- Analyst, Johns Hopkins Center for Health Security, Baltimore, Maryland; Research Associate, Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | - Syra Madad
- Senior Director, System-wide Special Pathogens Program, Central Office Emergency Management, Center for Global Healthcare Spe-cial Pathogens Preparedness, New York City, New York; Health+Hospitals, New York City, New York
| | - Jennifer B Nuzzo
- Senior Scholar, Johns Hopkins Center for Health Security, Baltimore, Maryland; Associate Professor, Department of Environmental Health and Engineering and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| |
Collapse
|
14
|
Pugel B, Popescu S, Madad S. Restricted and Uncontained: Health Considerations in the Event of Loss of Containment During the Restricted Earth Return of Extraterrestrial Samples. Health Secur 2020; 18:132-138. [PMID: 32324071 DOI: 10.1089/hs.2019.0088] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
The normal scope of an adequate public health response to released biological material is framed by working with biological vectors with known pathogenicity and virulence. Defining the scope of a response to the release of biological material with unknown pathogenicity and virulence enters into a novel and yet to be framed domain. A current case, in which extraterrestrial samples returned from a location such as Mars, which may harbor life as we know it, requires framing a public health response. An unintentional release of biological material with unknown pathogenicity and virulence may occur when biological containment mechanisms in the Earth-returning transport method are lost. This article raises initial public health and healthcare response questions during a return of extraterrestrial samples to Earth, in the event of its release from biological containment mechanisms: How does the public health community prepare for a response when there is release of samples that may contain potential extraterrestrial organisms from a planetary body or hardy terrestrial organisms surviving a round trip? If a mishap occurs during the return of these samples, what considerations need to be made to confine, decontaminate, and collect material in regions around the mishap? How will the public health community work with relevant government organizations to prepare the general public? The unknowns of exposure, potential extraterrestrial pathogenicity, and decontamination approaches underscore gaps in biopreparedness for this novel case from federal to local levels.
Collapse
Affiliation(s)
- Betsy Pugel
- Betsy Pugel, PhD, is Planetary Protection/Containment Control Engineer, NASA Goddard Space Flight Center, Greenbelt, MD
| | - Saskia Popescu
- Saskia Popescu, PhD, is Senior Infection Prevention Epidemiologist, HonorHealth, Phoenix, AZ
| | - Syra Madad
- Syra Madad, DHSc, is Senior Director, System-wide Ebola and Special Pathogens Program at NYC Health + Hospitals, New York, NY
| |
Collapse
|
15
|
Vasa A, Madad S, Larson L, Kraft CS, Vanairsdale S, Grein JD, Garland J, Butterworth VM, Kratochvil CJ. A Novel Approach to Infectious Disease Preparedness: Incorporating Investigational Therapeutics and Research Objectives into Full-Scale Exercises. Health Secur 2019; 17:54-61. [PMID: 30779611 DOI: 10.1089/hs.2018.0100] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The use of investigational therapeutics in the care of patients with Ebola virus disease was documented in the literature following the 2013-2016 outbreak. In order to access these types of therapeutics, facilities must have processes in place to quickly and efficiently activate study protocols, obtain the medications, and administer them in a timely manner. Testing these procedures in advance of a real-world event is crucial to ensuring successful implementation and execution. Drills and exercises are routinely used as part of the emergency preparedness planning process, as they provide a low-risk environment in which to test plans and procedures. Including research activities in full-scale emergency preparedness exercises is a novel approach that should be considered when creating a comprehensive special pathogen program. One important aspect of creating an agile response program is developing and sustaining strong relationships with key collaborators. Including departments not previously engaged in infectious disease preparedness exercises provides a forum to strengthen these relationships, clarify roles, and identify gaps. This article describes the process used to incorporate research-centric objectives focused on the use of investigational therapeutics for Ebola virus disease into a full-scale exercise, the evaluation process used to measure the identified objectives, and the results of the exercise.
Collapse
Affiliation(s)
- Angela Vasa
- Angela Vasa, BSN, RN, is Nurse Manager, Nebraska Medicine, Nebraska Biocontainment Unit, National Ebola Training and Education Center, Omaha, Nebraska
| | - Syra Madad
- Syra Madad, DHSc, MS, MCP, is Director, System-wide Ebola and Special Pathogens Program, NYC Health + Hospitals, and Assistant Professor, Graduate Biotechnology Program, University of Maryland
| | - LuAnn Larson
- LuAnn Larson, BSN, RN, is Director of Clinical Research Operations, University of Nebraska Medical Center, National Ebola Training and Education Center, Omaha, Nebraska
| | - Colleen S Kraft
- Colleen S. Kraft, MD, MSc, is Associate Professor, Department of Pathology and Laboratory Medicine, and Associate Professor, Division of Infectious Diseases, Emory University Hospital, Atlanta, GA
| | - Sharon Vanairsdale
- Sharon Vanairsdale, MS, is Program Director, Serious Communicable Diseases, Emory University Hospital, Atlanta, GA
| | - Jonathan D Grein
- Jonathan D. Grein, MD, is Director, Hospital Epidemiology, Division of Infectious Diseases, Cedars-Sinai Medical Center, and Associate Clinical Professor, David Geffen School of Medicine at UCLA, Los Angeles, CA
| | - Jennifer Garland
- Jennifer Garland, PhD, RN-BC, is Special Pathogens Clinical Program Coordinator, Department of Hospital Epidemiology, Cedars-Sinai Medical Center, Los Angeles, CA
| | - Virginia Madison Butterworth
- Virginia "Madison" Butterworth, MS, MEP, is an Emergency Preparedness Health Analyst, US Department of Health and Human Services, Washington, DC
| | - Christopher J Kratochvil
- Christopher J. Kratochvil, MD, is Associate Vice Chancellor for Clinical Research, University of Nebraska Medical Center; Vice President for Research, Nebraska Medicine; and Chief Medical Officer, UNeHealth, National Ebola Training and Education Center, Omaha, Nebraska
| |
Collapse
|